��������

Lawrence Lum is a seasoned scientist currently serving as the Chief Scientific Officer at Apertor Pharmaceuticals since 2023. They previously held leadership positions at Loxo Oncology at Lilly, Pfizer, and the University of Texas Southwestern Medical Center, where they achieved tenure as an Associate Professor. Lum completed their Doctor of Philosophy in Biochemistry at Weill Cornell Graduate School of Medical Sciences and earned a Bachelor's Degree in Biochemistry from the University of California, Berkeley. Their extensive experience in cancer research and therapeutics underscores their dedication to advancing scientific knowledge.